PepCalcs
    Back to Library

    SS-31

    Phase 2 TrialsReached Phase 3 trials for primary mitochondrial myopathy. The sponsor's program was disrupted by financial challenges.

    SS-31 (Elamipretide)

    Description

    A mitochondria-targeting antioxidant peptide that protects against oxidative stress. Studied for age-related diseases and cellular energy.

    Dose:500 mcg
    Frequency:5 days on, 2 days off (8 weeks on/off cycle)
    Administration Method: SQ, IV
    CategoryLongevity
    Half-LifeApproximately 2-5 hours (subcutaneous).

    Overview

    SS-31 (elamipretide) is a synthetic tetrapeptide developed by Drs. Hazel Szeto and Peter Schiller. It has been studied for cardiac mitochondrial dysfunction, ischemia-reperfusion injury, primary mitochondrial myopathy, and age-related mitochondrial decline.

    Mechanism of Action

    SS-31 (elamipretide) targets the inner mitochondrial membrane and interacts with cardiolipin, stabilizing the respiratory chain and improving mitochondrial bioenergetics.

    Benefits

    • Mitochondrial protection
    • Antioxidant
    • Cellular energy
    • Heart health
    • Age-related disease
    • Muscle function

    Dosing Notes

    Preclinical mouse studies of cisplatin-induced acute kidney injury used 10 mg/kg/day for 10 days.

    Reported Side Effects

    • Injection site reactions
    • Headache
    • Limited long-term human data

    Scientific References

    Related Longevity Peptides

    DISCLAIMER: FOR RESEARCH AND EDUCATIONAL PURPOSES ONLY

    The information provided on this website is for research and educational purposes only and is not intended for use in human medical treatment, diagnosis, or therapy. This site does not provide medical advice, and no content on this site should be considered a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of information obtained from this website. The calculations, dosage information, and peptide data provided are for informational and research purposes only. Use of this information for actual medical treatment or administration is done at your own risk. The operators of this site assume no liability for any actions taken based on the information provided herein.